US 9,808,417 B2
Compositions comprising Docynia delavajy extract and/or Elaeagnus lancelotus extract
Tiffany Florence, Dallas, TX (US); and Michelle Hines, Hickory Creek, TX (US)
Assigned to Mary Kay Inc., Addison, TX (US)
Filed by Mary Kay Inc., Addison, TX (US)
Filed on Oct. 19, 2016, as Appl. No. 15/297,440.
Application 15/297,440 is a continuation of application No. 14/693,589, filed on Apr. 22, 2015, granted, now 9,498,427.
Application 14/693,589 is a continuation of application No. 13/369,181, filed on Feb. 8, 2012, granted, now 9,040,104, issued on May 26, 2015.
Application 13/369,181 is a continuation of application No. 13/055,876, granted, now 8,137,714, issued on Mar. 20, 2012, previously published as PCT/US2009/051861, filed on Jul. 27, 2009.
Claims priority of provisional application 61/083,782, filed on Jul. 25, 2008.
Claims priority of provisional application 61/083,797, filed on Jul. 25, 2008.
Prior Publication US 2017/0035684 A1, Feb. 9, 2017
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 8/97 (2017.01); A61K 36/185 (2006.01); A61Q 19/02 (2006.01); A61Q 19/08 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61Q 19/00 (2006.01); A61K 8/06 (2006.01)
CPC A61K 8/97 (2013.01) [A61K 8/064 (2013.01); A61K 9/0014 (2013.01); A61K 9/08 (2013.01); A61K 36/185 (2013.01); A61Q 19/007 (2013.01); A61Q 19/02 (2013.01); A61Q 19/08 (2013.01); A61K 2800/31 (2013.01); A61K 2800/48 (2013.01); A61K 2800/782 (2013.01)] 12 Claims
 
1. A method of treating skin in need thereof, the method comprising topically applying to the skin a composition comprising an effective amount of an ethanolic or a butanolic extract from the leaf and stem of Docynia delavajy, wherein the composition reduces oxidation in the skin, reduces tumor necrosis factor-alpha (TNF-α) in the skin, or reduces metalloprotease-1 (MMP-1) activity in the skin.